Thursday, July 9, 2026

pharma · Prostate Cancer · Myelodysplastic Syndromes · SNSE

Sensei Biotherapeutics

Sensei Biotherapeutics patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

ROCKVILLE, MD, USA HQ
2 Employees
Public company Type
SNSE · NYSE Ticker
Company details
Status
Public
HQ
ROCKVILLE, MD, USA
Employees
2
Programs
3
Drugs
0
Patents
1
Intelligence · Patents

Sensei Biotherapeutics patents

1 pharmaceutical patents indexed for Sensei Biotherapeutics. 0 expire within 24 months.

Sensei Biotherapeutics has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 11932695

    Modified antibodies and related compounds, compositions and methods of use

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Sensei Biotherapeutics have?

1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Sensei Biotherapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.